Zhou Xin, Xu MengMeng, Wang Liyang, Mu Yulian, Feng Rui, Dong Zhilong, Pan Yuexin, Chen Xunzhang, Liu Yongfeng, Zheng Shangen, Anthony Donald D, Ma Jianjie, Isaacs Williams B, Xu Xuehong
College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710062 China.
Department of Pharmacology, Duke University Medical Center, Durham, NC 27708 USA.
Genes Nutr. 2016 May 21;11:14. doi: 10.1186/s12263-016-0529-z. eCollection 2016.
Environmental factors are well-known causes of diseases. However, aside from a handful of risk indicators, genes' encoding susceptibility to chronic illnesses and their associated environmental triggers are largely unknown. In this era of increasingly rich diets, such genetic predispositions would be immensely helpful from a public health perspective. The novel transgenic mouse model with liver-specific NG37 overexpression characterized in this article identifies the diet-dependent function of NG37 in the pathogenesis of fatty liver disease and cardiac arrhythmia.
The liver-specific NG37 overexpression transgenic mouse model described here was generated using the Alb-SV40 polyA expression plasmid backbone. NG37 cDNA under control of the albumin promoter for liver-specific expression was fused with a 5' terminal M2 FLAG sequence and a SV40 early region transcription terminator/polyadenylation site attached at the 3'-UTR. These NG37 transgenic mice developed normally and were physiologically normal on a standard diet. However, in comparison to non-transgenic (nTG) litter mates, these mice develop dramatic phenotypes within 12-18 days of starting a high-fat diet: (i) increased body weight (28.5 ± 12.3 g), (ii) increased liver weight (87.4 ± 35.7 mg), (iii) increased heart weight (140 ± 38.4 mg), and (iv) cardiac arrhythmia. The enlarged livers of high-fat diet NG37 transgenic mice was histologically similar to human fatty liver disease and contained Maltese cross birefringent active depositions in hepatocytes that are indicative of fatty liver disease. We also confirmed via X-ray diffraction the steatotic vesicles in the diseased hepatocytes of our high-fat diet NG37 mice was composed of cholesteryl derivatives also found in human fatty liver disease. In addition to cardiac enlargement, NG37 transgenic mice on high-fat diet also exhibited highly irregular bradycardia not present in either high-fat diet nTG littermates or normal-diet transgenic litter mates.
The dramatic high-fat diet-dependent symptoms (increased body weight, cardiac enlargement, fatty liver, and cardiac arrhythmias) characterized in our liver-specific NG37 overexpression mouse model identifies NG37 as a gene encoding latent lipid metabolism pathology induced only in the presence of an environmental factor relevant to human health: high-fat diet.
环境因素是众所周知的疾病病因。然而,除了少数风险指标外,基因编码对慢性疾病的易感性及其相关的环境触发因素在很大程度上尚不清楚。在这个饮食日益丰富的时代,从公共卫生角度来看,这种遗传易感性将非常有帮助。本文中表征的具有肝脏特异性NG37过表达的新型转基因小鼠模型确定了NG37在脂肪肝疾病和心律失常发病机制中的饮食依赖性功能。
这里描述的肝脏特异性NG37过表达转基因小鼠模型是使用Alb-SV40 polyA表达质粒骨架构建的。在白蛋白启动子控制下用于肝脏特异性表达的NG37 cDNA与5'末端M2 FLAG序列融合,并在3'-UTR处连接SV40早期区域转录终止子/聚腺苷酸化位点。这些NG37转基因小鼠发育正常,在标准饮食下生理正常。然而,与非转基因(nTG)同窝仔相比,这些小鼠在开始高脂饮食后的12 - 18天内出现显著的表型:(i)体重增加(28.5±12.3克),(ii)肝脏重量增加(87.4±35.7毫克),(iii)心脏重量增加(140±38.4毫克),以及(iv)心律失常。高脂饮食的NG37转基因小鼠肝脏肿大,组织学上与人类脂肪肝疾病相似,肝细胞中含有马耳他十字双折射活性沉积物,这表明存在脂肪肝疾病。我们还通过X射线衍射证实,我们高脂饮食的NG37小鼠患病肝细胞中的脂肪变性小泡由在人类脂肪肝疾病中也发现的胆固醇衍生物组成。除了心脏肿大外,高脂饮食的NG37转基因小鼠还表现出高度不规则的心动过缓,这在高脂饮食的nTG同窝仔或正常饮食的转基因同窝仔中均未出现。
我们的肝脏特异性NG37过表达小鼠模型中表征的显著的高脂饮食依赖性症状(体重增加、心脏肿大、脂肪肝和心律失常)确定NG37是一种仅在存在与人类健康相关的环境因素:高脂饮食时才诱导潜在脂质代谢病理的基因。